- TYROSINE KINASE INHIBITORS
-
The present disclosure provides compounds that are tyrosine kinase inhibitors, in particular Bruton tyrosine kinase ( BTK ) inhibitors, and are therefore useful for the treatment of diseases treatable by inhibition of BTK such as cancer, autoimmune, inflammatory, and thromboembolic diseases. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
- -
-
Page/Page column 85
(2016/12/22)
-
- ORGANIC COMPOUNDS
-
The application relates to novel amino alcohols of general formula (I) where R, R1, R2,R3, R4, R5,X1 and X2 each have the definitions illustrated in detail in the des
- -
-
Page/Page column 31
(2010/02/13)
-
- DIAMINO ALCOHOLS AND THEIR USE AS RENIN INHIBITORS
-
The application relates to novel amino alcohols of the general formula (I) where R, R1, R2, R3,R4, R5 and R6 each have the definitions illustrated in detail in the description, to a process for their preparation, and to the use of these compounds as medicines, in particular as renin inhibitors.
- -
-
Page/Page column 33
(2010/02/13)
-